IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Positive IHL-675A in vivo results and FDA Pathway, page-72

  1. 933 Posts.
    lightbulb Created with Sketch. 1446
    ARDS alone is a multi billion dollar per year addressable market, even without COVID-19.

    This does not take into account the potential market contemplated within the expanded patent relating to other sepsis and inflammation conditions.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.